Log in to save to my catalogue

The spliceosome is a therapeutic vulnerability in MYC-driven cancer

The spliceosome is a therapeutic vulnerability in MYC-driven cancer

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4831063

The spliceosome is a therapeutic vulnerability in MYC-driven cancer

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

Splicing factors such as BUD31 are identified in a synthetic-lethal screen with cells overexpressing the transcription factor MYC; oncogenic MYC leads to an increase in pre-mRNA synthesis, and spliceosome inhibition impairs the growth and tumorigenicity of MYC-dependent breast cancers, suggesting that spliceosome components may be potential therape...

Alternative Titles

Full title

The spliceosome is a therapeutic vulnerability in MYC-driven cancer

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4831063

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4831063

Other Identifiers

ISSN

0028-0836

E-ISSN

1476-4687

DOI

10.1038/nature14985

How to access this item